Byoung-Ryun Kim Selected Research

Byoung-Ryun Kim Research Topics

9	Lung Neoplasms (Lung Cancer) 01/2017 - 10/2011
5	Neoplasms (Cancer) 01/2017 - 10/2011
3	Malignant Pleural Effusion 01/2017 - 02/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2015 - 05/2014
3	Mitochondrial Diseases (Mitochondrial Disease) 05/2015 - 07/2013
2	Pleural Effusion (Pleural Effusions) 01/2017 - 02/2012
2	Malignant Mesothelioma 05/2015 - 10/2014
1	Carcinoma (Carcinomatosis) 01/2017
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017
1	Tuberculosis (Tuberculoses) 01/2017
1	Carcinogenesis 01/2017
1	Mesothelioma 05/2015

4	Simvastatin (Zocor)FDA LinkGeneric 10/2014 - 10/2011
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2015 - 07/2013
2	Tumor Biomarkers (Tumor Markers)IBA 01/2017 - 02/2012
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 02/2012
2	Sulindac (Copal)FDA LinkGeneric 08/2016 - 07/2013
2	Sirtuin 1IBA 08/2016 - 05/2015
2	Folic Acid AntagonistsIBA 05/2015 - 10/2014
2	Pemetrexed (MTA)FDA Link 05/2015 - 10/2014
2	Small Interfering RNA (siRNA)IBA 05/2015 - 07/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2013 - 10/2011
2	SurvivinIBA 02/2012 - 10/2011
1	Heterogeneous Nuclear Ribonucleoprotein A1IBA 01/2017
1	RNA Splicing FactorsIBA 01/2017
1	Arginine (L-Arginine)FDA Link 01/2017
1	EnzymesIBA 01/2017
1	ImmunosorbentsIBA 01/2017
1	Serine (L-Serine)FDA Link 01/2017
1	CytokinesIBA 01/2017
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Celecoxib (Celebrex)FDA Link 08/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2016
1	ResveratrolIBA 05/2015
1	Acetylcysteine (Siran)FDA LinkGeneric 10/2014
1	Gefitinib (Iressa)FDA Link 05/2014
1	ErbB Receptors (EGF Receptor)IBA 05/2014
1	Tyrosine Kinase InhibitorsIBA 05/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2014
1	Docetaxel (Taxotere)FDA Link 07/2013
1	CaspasesIBA 07/2013
1	C-Reactive ProteinIBA 03/2013
1	antigen CYFRA21.1IBA 02/2012

1	Chemoprevention 07/2013
1	Drug Therapy (Chemotherapy) 02/2012